aroplatin
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 6, 2002 (NCT00043199)
Timeline
Indications
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Chemistry & pharmacology
- Mol. weight
- 651.79 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297263 ↗
Also known as
- aroplatin
- aroplatin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00316511 | Phase 1 | Mar 1, 2006 | Agenus Inc. |
| NCT00081536 | Phase 1/Phase 2 (Phase 2) | Apr 15, 2004 | Aronex Pharmaceuticals |
| NCT00081549 | Phase 1/Phase 2 (Phase 2) | Apr 15, 2004 | Aronex Pharmaceuticals |
| NCT00057395 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2003 | Aronex Pharmaceuticals |
| NCT00043199 | Phase 2 | Aug 6, 2002 | Aronex Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aronex Pharmaceuticals | For profit | 4 | 4 | 1 | 2002 |
| Agenus Inc. | For profit | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1